HIGHLIGHTS
- who: Hyun Young Woo and colleagues from the Department of Internal Medicine, College of Medicine, Pusan National University and Research Republic of Korea have published the research work: Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial, in the Journal: PLOS ONE of January/25,/2022
- what: This study investigated whether switching to peginterferon (PegIFN) alfa-2a after long-term NA therapy induced a durable viral response. The aim of this study was to compare the effects of a 48 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.